Well-Konnect Healthcare Services and Research Firm

Well-Konnect Healthcare Services and Research Firm is a Washington, D.C.-based clinical research organization and healthcare consulting firm specializing in a multidisciplinary approach to complex health conditions. The company is actively involved in clinical research, notably sponsoring a Phase 4 trial evaluating the efficacy of vaccines and antiviral treatments for Long COVID (Post-COVID Syndrome). Additionally, the firm explores regenerative medicine through stem cell therapies and promotes health equity via genomic research and health literacy programs. Utilizing its proprietary Well-Konnect Biopsychosocial Framework (WKBF tool), the organization aims to provide personalized, evidence-based care to marginalized communities. Led by Dr. Kawana Williams, the firm collaborates with major initiatives such as the NIH All of Us Research Program.